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Maternal obesity is known to increase the risk of obesity and diabetes in offspring. Though diabetes is a 
key risk factor for the development of chronic kidney disease (CKD), the relationship between maternal 
obesity and CKD has not been clearly defined. In this study, a mouse model of maternal obesity was 










obesity should be considered a risk factor for CKD.
Diabetic nephropathy is an important complication of diabetes and is the leading cause of end-stage kidney dis-
ease worldwide1. In type 1 diabetes, the risk of diabetic nephropathy is associated with longer duration of diabe-
tes, poor glycemic control, hypertension and dyslipidemia2. Yet, it is poorly understood why, despite multiple risk 
factors for renal disease, some individuals appear to be unaffected by renal complications while others seem to be 
highly susceptible to diabetic nephropathy3. Moreover, there appear to be less well-defined precipitating factors 
for diabetic nephropathy. Interestingly, recent studies have suggested that maternal factors impacting foetal expo-
sure in utero may contributes to increased risk of kidney disease in adulthood4–6. This concept of developmental 
programming is increasingly understood to have long-lasting consequences on renal health.
Developmental programming due to foetal exposure to maternal obesity significantly increases the risk of 
metabolic syndrome and its sequelae in offspring7,8. Metabolic syndrome is a cluster of multiple medical comor-
bidities underpinned by obesity and insulin resistance9. A retrospective case control study of over 1 million per-
son years found a 35% increased risk of mortality and 29% greater risk of cardiovascular death in offspring born 
to obese mothers compared to non-obese mothers10. Both rodent and primate models of maternal high-fat diet 
(HFD) feeding have identified that offspring of obese mothers are at increased risk of obesity, glucose intolerance 
and diabetes, hepatic steatosis and endothelial injury11,12. Though the kidney is a highly vascular organ that is very 
responsive to hemodynamic, metabolic and inflammatory changes13, the link between maternal obesity and CKD 
has not clearly been made.
Our recent studies have identified that rodent offspring of obese mothers have increased renal damage includ-
ing fibrosis, inflammatory and oxidative stress changes14. As such, exposure to maternal obesity in utero may 
propagate renal dysfunction in offspring through increasing the risk of metabolic syndrome, which can fur-
ther be compounded by the development of diabetes later in life. Thus, the aim of this study was to determine 
whether maternal obesity increases diabetic nephropathy in rodent offspring with diabetes. Specifically, we aimed 
1Department of Medicine, Kolling Institute, University of Sydney, Sydney, Australia. 2Department of Diabetes, 
Endocrinology and Metabolism, Royal North Shore Hospital, St Leonards, Australia. 3School of Life Sciences, 
Faculty of Science, University of Technology Sydney, Australia. Correspondence and requests for materials should 
be addressed to S.J.G. (email: sarah.glastras@sydney.edu.au)
Received: 02 April 2016
Accepted: 25 May 2016
Published: 09 June 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:27769 | DOI: 10.1038/srep27769
to determine whether maternal obesity: (1) leads to changes in renal physiology in offspring at adulthood and, (2) 
exacerbates renal damage in diabetic offspring, and importantly explore the mechanisms of these effects.
Results
Serum metabolic measures. To confirm the diabetic phenotype of mice treated with STZ, indices of gly-
caemia were assessed. As expected, at the endpoint of Week 32 fasting glucose levels and HbA1c were signifi-
cantly higher in offspring treated with STZ compared to controls (p < 0.01, Table 1). Thus, STZ induced diabetes 
in treated animals. There was no difference in fasting glucose or HbA1c between non-diabetic offspring of lean 
versus obese mothers. Serum insulin levels were increased in offspring of obese mothers; however they were 
significantly lowered in the offspring with diabetes, in keeping with STZ treatment-induced pancreatic β-cell 
depletion. Serum triglycerides and NEFA were higher in offspring of obese mothers at postnatal Week 32. HFD 
induced hypertriglyceridaemia in the offspring, which was reduced in the presence of diabetes (p < 0.01, Table 1).
Biometric parameters.  Total body weight was reduced in offspring with diabetes at 32 weeks of age, irre-
spective of maternal weight, although kidney/total body weight was similar in all groups (Table 1). Maternal 
obesity alone did not have a sustained effect on body weight or fasting glucose levels in chow-fed offspring. 
However, there was significantly increased retroperitoneal and epididymal fat deposits in offspring of obese 
mothers (p < 0.01). As expected, fat deposits were reduced in diabetic animals, more so in offspring of the obese 
mothers (Table 1). Liver size was non-significantly increased by diabetes.
Renal functional and structural changes.  The renal function of offspring from obese mothers was con-
siderably worse in comparison to non-obese mothers, especially when they developed diabetes. Both diabetes and 
maternal obesity increased serum creatinine (CCT1D vs. CC, HC vs. CC and HCT1D vs. CC, P < 0.05, Table 1). 
24 h urinary albumin excretion was significantly increased by maternal obesity independent of the development 
of diabetes and the 24 h urinary albumin excretion was significantly increased in diabetic mice, regardless of the 
maternal diet (P < 0.05, Table 1). In addition, diabetic animals had polyuria as evidenced by more than three-fold 
increase in urine output over 24 h (CCT1D vs. CC and HCT1D vs. CC, P < 0.05, Table 1). There was no significant 
difference in urine output between offspring of obese mothers compared to control.
Objective increases in tubular injury score, determined by Masson trichrome staining, were found in offspring 
with diabetes regardless of maternal diet (P < 0.01, CC-ctrl vs. CC-T1D; P < 0.01, HC-ctrl vs. HC-T1D) and 
non-diabetic offspring by maternal obesity (P < 0.05, CC-ctrl vs. HC-ctrl, Fig. 1A,C). Similarly, the glomerulo-
sclerosis score obtained by PAS staining was significantly increased by diabetes (P < 0.01, CC-ctrl vs. CC-T1D; 
P < 0.01, HC-ctrl vs. HC-T1D) and maternal obesity (P < 0.05 CC-ctrl vs. HC-ctrl, Fig. 1B,D).
Maternal obesity induced renal fibrosis in the presence of diabetes in offspring.  To determine 
whether maternal obesity impacted upon renal fibrosis in offspring, quantitative western blotting and immu-
nohistochemistry were carried out. Protein expression of collagen IV by both Western blotting was increased 
by maternal obesity in combination with diabetes (P < 0.05, CC-ctrl vs. HC-T1D, P < 0.05, CC-T1D vs. HC- 
T1D, Fig. 2A). Immunohistochemistry confirmed diabetes increased collagen IV expression compared to con-
trol though there was no exacerbating effect of maternal obesity in addition to diabetes (P < 0.05, CC-ctrl vs. 
HC-T1D, Fig. 2B,C). Likewise, fibronectin protein level measured by western blotting was greater in the diabe-
tes group (P < 0.01, CC-ctrl vs. CC-T1D) and also in mice from obese mothers (P < 0.05, CC-ctrl vs. HC-ctrl, 
Fig. 3A). There was no significant difference in fibrosis markers when diabetic offspring from lean and obese 
mothers were compared, suggesting that maternal obesity does not potentiate fibrosis in the presence of diabetes. 
This finding was confirmed by immunohistochemistry staining (Fig. 3B,C).
CC-ctrl CC-T1D HC-ctrl HC-T1D
Body weight (g) 26.97 ± 0.37 23.79 ± 0.62** 26.84 ± 0.83 24.20 ± 0.54**
Kidney/Body (% total) 0.85 ± 0.39 0.80 ± 0.74 0.76 ± 0.70 0.75 ± 0.53
Liver/Body (% total) 5.42 ± 0.24 5.48 ± 0.12 5.35 ± 0.19 5.88 ± 0.19
Epididymal mass (% total) 1.59 ± 0.11 1.48 ± 0.15 2.12 ± 0.20# 1.33 ± 0.13**
Retroperitoneal fat (% total) 0.54 ± 0.05 0.46 ± 0.06 0.81 ± 0.07## 0.39 ± 0.05**
Glucose (mmol/L) 14.11 ± 0.46 22.23 ± 0.97** 15.43 ± 0.51 20.28 ± 1.10**
HbA1c (%) 4.51 ± 0.06 5.85 ± 0.24** 4.36 ± 0.11 5.65 ± 0.25**
HbA1c (mmol/mol) 25.76 ± 0.82 40.44 ± 2.97 ** 24.15 ± 2.00 38.21 ± 3.02 **
Serum insulin (pmol/L) 67.72 ± 1.97 8.46 ± 3.10** 21.10 ± 5.10# 4.57 ± 2.30**
Serum NEFA (mmol/L) 0.81 ± 0.06 1.06 ± 0.10 1.06 ± 0.23# 1.66 ± 0.18**
Serum triglycerides (mmol/L) 0.25 ± 5.54 0.67 ± 2.01* 0.93 ± 3.49***## 0.43 ± 0.72**
Serum Creatinine (μmol/L) 24.00 ± 0.55 28.67 ± 1.28* 28.00 ± 0.72* 28.00 ± 1.844*
Urine volume (mL/24 h) 0.50 ± 0.11 1.67 ± 0.57* 0.89 ± 0.16 1.62 ± 0.34*
24 h urinary albumin (mg/24 h) 7.71 ± 1.87 31.01 ± 7.00* 30.07 ± 3.87# 42.66 ± 7.55 *
Table 1.  Body/metabolic parameters at 32 weeks of age (n = 6–12), *P < 0.05, **P < 0.01, compared with 
non-diabetic littermates. #P < 0.05, ##P < 0.01. Compared with the control mice with the same treatment, 
results are expressed as mean ± SEM, n = 6–12.
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Maternal obesity exacerbates the impact of diabetes on renal inflammation.  Inflammatory 
changes in the kidney are a hallmark of renal dysfunction in diabetic nephropathy. In keeping with this obser-
vation, MCP-1 mRNA expression was greater in the kidneys of offspring with diabetes (P < 0.05, CC-ctrl 
vs. CC-T1D and HC-T1D, Fig. 4A). Furthermore, levels of the macrophage marker CD68 were significantly 
increased by diabetes (P < 0.01, HC-ctrl vs. HC- T1D) and maternal obesity (P < 0.05, CC-ctrl vs. CC-T1D, 
Fig. 4B,C). Similarly, levels of the inflammatory marker F4/80 were higher in the presence of diabetes (P < 0.05, 
CC-ctrl vs. CC-T1D, P < 0.05, HC-ctrl vs. HC-T1D) and maternal obesity (P < 0.05, CC-ctrl vs. HC-ctrl, 
Fig. 4D,E). Moreover, the combination of maternal obesity and diabetes gave rise to significantly increased levels 
of F4/80 compared to diabetes alone (P < 0.01, CC- T1D vs. HC-T1D). Therefore, though maternal obesity in the 
presence of diabetes had no effect on MCP1 expression, it significantly increased CD68 and F4/80.
Maternal obesity exacerbates the effect of diabetes on renal oxidative stress.  Enhanced levels 
of oxidative stress were observed in the kidneys of offspring of obese mothers, as well as those with diabetes. 
iNOS mRNA expression was significantly potentiated in offspring of obese mothers with diabetes compared to 
diabetes alone (P < 0.05, CC-T1D vs. HC-T1D, P < 0.05, HC-ctrl vs. HC-T1D, Fig. 5A). Mitochondrial antioxi-
dant, MnSOD was increased in response to oxidative stress in the kidneys of offspring from obese mothers with 
diabetes (P < 0.05, CC-T1D vs. HC-T1D, P < 0.05, HC-ctrl vs. HC-T1D, Fig. 5B). Furthermore, immunohisto-
chemistry staining showed 8-OHdg, the major product of DNA oxidation, was significantly increased by diabetes 
(P < 0.01 CC-ctrl vs. CC-T1D) and maternal obesity (P < 0.001, CC-ctrl vs. HC-ctrl, Fig. 5C,D). Maternal obesity 
increased 8OH-dg expression. T1D also increased 8-OHdg to similar levels. Interestingly, T1D in the presence 
of maternal obesity significantly increased 8-OHdg compared to T1D alone (p < 0.01, CC-T1D vs. HC-T1D, 
Fig. 5C,D).
Discussion
The results of this study indicate that maternal obesity is associated with renal damage in rodent adult offspring, 
which is further amplified when diabetes supervenes. Functional and structural changes were seen in the kidneys of 
diabetic offspring consistent with a model of diabetic nephropathy. Maternal obesity was associated with reduced 
renal function as measured by serum creatinine and increased renal fibrosis as measured by renal structural changes 
Figure 1. Renal structural changes associated with maternal obesity and diabetes: (A) Masson trichrome 
staining representative image at x20 magnification, (B) Periodic acid Schiff staining (PAS) representative 
image at x20 magnification (C) Interstitial fibrosis score assessed by Masson trichrome staining and (D) 
Glomerulosclerosis score assessed by PAS staining. Results are expressed as mean ± SEM, n = 12. *P < 0.05,  
**P < 0.01, ***P < 0.001, ****P < 0.0001; offspring from lean mothers (control): CC-ctrl, type 1 diabetic 
offspring from lean mothers: CC-T1D, offspring from obese mothers: HC-ctrl and offspring from obese 
mothers with type 1 diabetes: HC-T1D.
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and fibronectin. Both renal inflammation and oxidative stress were exacerbated in offspring born to obese mothers, 
further amplified by diabetes, suggesting an important role of developmental programming in the kidney.
The mechanisms underpinning developmental programming of metabolic disease are complex and yet to be 
fully elucidated, however inflammation and oxidative stress have an integral role in the propagation of metabolic 
dysfunction between generations15,16. In addition, there is considerable evidence to support the hypothesis that 
maternal obesity has significant effects on central pathways for energy homeostatic regulation and reward-driven 
behavior17–22. As a consequence, maternal overnutrition increases adipogenesis and lipogenesis in offspring and 
leads to adipocyte hyperplasia and hypertrophy due to excessive lipid accumulation, with steatosis occurring 
in the hepatocytes23–30. In this study, we found no difference in total adult body weight between offspring of 
obese versus lean mothers. This is perhaps due to the fact that the offspring were only exposed to a balanced and 
non-obesogenic diet after weaning. However, the offspring of obese mothers still had increased retroperitoneal 
and epididymal fat deposits, suggesting body weight does not accurately reflect adiposity. In fact, the concept of 
normal weight obesity has been proposed, which link this phenomenon to a significantly higher risk of metabolic 
syndrome, cardiovascular dysfunction and higher mortality rate31,32. This clearly can be exaggerated by the addi-
tional ad libitum HFD consumption21. However the impact of maternal obesity on kidney pathology in the setting 
of renal lipid accumulation has not been well studied.
Adipocytes are key secretors of pro-inflammatory cytokines. Indeed, we have previously shown that 
inflammatory cytokines including IL-6, MCP-1 and TGFβ are increased in the serum of rat offspring of obese 
mothers, as well as in their kidneys14,33. Thus, exposure to maternal obesity may prime offspring towards a 
pro-inflammatory state, thereby increasing their susceptibility to complications of obesity and kidney disease at 
a later stage. Diabetes itself, even type 1 diabetes in the absence of obesity, is known to foster a pro-inflammatory 
Figure 2. Renal fibrotic changes as measured by Collagen IV: (A) Collagen IV protein expression measured 
by Western blotting (n = 3–5 per group), gels have been run at the same time under the same experimental 
conditions, (B) immunohistochemistry representative image of CIV staining at x20 magnification 
representative blot (C) area % CIV expression (n = 4–6 per group), *P < 0.05, **P < 0.01, ***P < 0.001; offspring 
from lean mothers (control): CC-ctrl, type 1 diabetic offspring from lean mothers: CC-T1D, offspring from 
obese mothers: HC-ctrl and offspring from obese mothers with type 1 diabetes: HC-T1D.
Figure 3. Renal fibrotic changes as measured by fibronectin: (A) Fibronectin protein expression by Western 
blotting (n = 4–6 per group), gels have been run at the same time under the same experimental conditions, 
(B) immunohistochemistry representative image of fibronectin staining at x20 magnification representative 
blot (n = 4–5 per group), (C) area % fibronectin expression. Results are expressed as mean ± SEM, n = 4–6 
per group. *P < 0.05, **P < 0.01: offspring from lean mothers (control): CC-ctrl, type 1 diabetic offspring from 
lean mothers: CC-T1D, offspring from obese mothers: HC-ctrl and offspring from obese mothers with type 1 
diabetes: HC-T1D.
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state and the pathophysiological mechanisms underlying the development of diabetic nephropathy is increasingly 
being recognized to involve inflammatory processes34,35. Herein, we report that renal inflammation is exacerbated 
in the kidneys of diabetic offspring, as a consequence of early exposure to maternal obesity. We found that MCP-1 
Figure 4. Renal inflammation associated with maternal obesity and diabetes: (A) MCP-1 mRNA expression, 
(B–C) CD68 immunohistochemistry staining, and (D–E) F4/80 immunohistochemistry staining. Results are 
expressed as mean ± SEM, n = 6 per group. *P < 0.05; **P < 0.01, ***P < 0.001; offspring from lean mothers 
(control): CC-ctrl, type 1 diabetic offspring from lean mothers: CC-T1D, offspring from obese mothers: HC-ctrl 
and offspring from obese mothers with type 1 diabetes: HC-T1D.
Figure 5. Oxidative stress measures associated with maternal obesity and diabetes: (A) iNOS mRNA 
expression, (B) MnSOD protein expression by Western blotting, gels have been run at the same time under the 
same experimental conditions, and (C,D) 8OHdg immunohistochemistry staining. Results are expressed as 
mean ± SEM, N = 3–6 per group. *P < 0.05; **P < 0.01, ***P < 0.001; offspring from lean mothers (control): 
CC-ctrl, type 1 diabetic offspring from lean mothers: CC-T1D, offspring from obese mothers: HC-ctrl and 
offspring from obese mothers with type 1 diabetes: HC-T1D.
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and macrophage markers CD68 and F4/80 were increased. MCP-1 is an important chemokine, playing a key role 
in monocyte/macrophage recruitment and contributing to inflammation in diabetic nephropathy36,37. We further 
observed that maternal obesity together with diabetes exaggerated inflammatory cell accumulation in the kidney, 
as seen by increases in both CD68 and F4/80. The inflammatory cells (i.e. macrophages) recruited from the circu-
lation into the interstitium play an active role in tubulointerstitial fibrogenesis38, which was also well represented 
in the offspring’s kidneys at 32 weeks.
Oxidative stress plays a critical role in the pathophysiology of several kidney diseases and has been implicated 
in the development of diabetic kidney disease in humans and mice39–42. Furthermore, recent studies suggest 
that production of reactive oxidative species (ROS) in the liver and adipose tissue may precede the onset of foe-
tal weight gain in response to abnormal maternal nutrition in utero17,43. Nutrient excess leads to mitochondrial 
dysfunction, which in turns gives rise to obesity related pathologies, in part due to the harmful effects of ROS44. 
Mitochondrial dysfunction has been reported as early as embryogenesis in offspring of obese mice, with the 
oocytes and zygotes having increased mitochondrial membrane potential, higher levels of oxidative phosphoryl-
ation and increased ROS production45. Mitochondrial DNA (mtDNA) is highly sensitive to the deleterious effects 
of ROS46. The kidney is also highly susceptible to the effects of oxidative stress and mitochondrial dysfunction due 
to their high metabolic throughput. Indeed, mice with mtDNA mutations die prematurely due to renal failure, 
suggesting a link between mitochondrial dysfunction and renal disease47. To date, no studies have examined the 
influence of maternal obesity on renal markers of oxidative stress in the context of diabetes. Our findings in this 
study represent the first evidence of the powerful additive effect of maternal obesity and diabetes on oxidative 
stress and tissue damage within the kidney. Not only were oxidative stress markers iNOS and 8-OHdg increased 
but the antioxidant MnSOD was increased; MnSOD is a mitochondrial enzyme that scavenges reactive oxygen 
species and is known to be upregulated in the context of cellular stress48.
In this study we found only mild to moderate glomerulosclerosis and interstitial fibrosis and there was no 
extensive proteinuria or frank renal sclerosis. Collagen IV expression was variable between western blotting and 
immunohistochemistry, likely due to the pattern of expression of collagen IV. Specifically, collagen IV is known 
to be expressed in both the medulla and cortex of the kidney49. Therefore, immunohistochemistry analysis bet-
ter reflects cortical collagen IV expression, known be relevant to renal fibrosis. Our data clearly showed that 
collagen IV as well as fibronectin werer significantly increased in offspring of obese mothers with diabetes. The 
Animal Models of Diabetic Complications Consortium have set forth guidelines for the use of animal models of 
diabetic nephropathy. They have recommended against the usage of C57BL/6 mice as a model of diabetes and its 
complications due to the relative resistance of the strain to diabetic nephropathy50. However, though genetically 
manipulated animal models such as the eNOS knockout mouse are good models for diabetic nephropathy, they 
are resistant to the effects of HFD-feeding and this makes them less useful as a model of maternal obesity. Despite 
the known limitations of the model employed in the present study, there was still significant renal damage in 
terms of fibrosis in the offspring. This suggests the potent impact of maternal obesity and diabetes to induce renal 
disorders that can ultimately lead to the development of CKD.
In summary, maternal obesity increases fibrotic, inflammatory and oxidative stress changes in the kidneys of 
offspring. As expected, diabetes is associated with renal damage involving similar underlying changes. Maternal 
obesity potentiates the deleterious effects of insulin-insufficient diabetes on offspring kidney health, particularly 
renal inflammation and oxidative stress. Thus, maternal weight in pregnancy is an important modifiable risk 
factor for the development of renal disease in offspring later in life.
Methods
Animal experiments.  A schematic representation of the animal model is shown in Fig. 6. Female C57BL/6 
mice were fed either high fat diet (HFD, 20 kJ/g, 43% fat; SF03-020, Specialty Feeds, WA, Australia)) or stand-
ard rodent chow (11 kJ/g, 14% fat, Gordon’s Specialty Stockfeeds, NSW, Australia) for six weeks prior to mating 
(n = 12). They were mated for 24 hours, pregnancy confirmed by vaginal plug and then maintained on the same 
diet throughout gestation and lactation. Litters were adjusted to 4–6 pups at postnatal Day 1. Male pups were 
weaned at postnatal day 20 (normal weaning age) and fed chow. At postnatal week 8, mice were assigned to 
receive either low-dose streptozotocin (STZ) or placebo. Mice receiving low-dose STZ were fasted for 5 h prior to 
injection. STZ (55 mg/kg, Sigma, MO, USA) was prepared fresh in 0.1 M citrate buffer, pH 4.5 and administered 
over 5 consecutive days. Animals in the control group were administered citrate buffer.
After fasting for 6 h, mice were weighed and their blood glucose levels were measured fortnightly using an 
Accuchek glucometer (Roche Diagnostics). Animals with blood glucose >16 mmol/L were considered diabetic. 
Diabetic mice received insulin treatment (Glargine, Sanofi, Germany) to control ketosis if their blood glucose 
level was >25 mmol/L; following insulin treatment, their blood glucose readings were performed twice weekly.
Mice were placed in metabolic cages and 24-h urine collection was performed one week prior to animal 
sacrifice. Urine albumin levels were determined using the Murine Microalbuminuria ELISA kit (Exocell, Inc., 
Philadelphia, PA, USA).
Animal sacrifice took place at Week 32 under fasting conditions. The body was perfused with PBS, and the 
kidneys, liver, pancreas and fat were weighed and collected, either snapped frozen for RNA and protein quantifi-
cation or fixed in 10% buffered formalin for histological examination.
All animals were housed in the Kearns Animal Facility of Kolling Institute, Royal North Shore Hospital and 
maintained at 22 ± 1 °C with a 12/12-h light–dark cycle. All procedures were approved by the Animal Ethics 
Committee (AEC) of Royal North Shore Hospital (AEC 1309-007A) and complied with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes.
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Serum measures. Glycosylated hemoglobin (HbA1c) was measured using a DCA Vantage Analyzer 
(Siemens Medical Solutions Diagnostics, Tarrytown, NY). To measure serum triglycerides, plasma samples as well 
as glycerol standards (Sigma-Aldrich, St Louis, MO, USA) were incubated with triacylglycerol reagent (Roche 
Diagnostics) and concentration was determined using the colorimetric method on a Bio-Rad 680 XR (Hercules, 
CA, USA). Plasma non-esterified fatty acid (NEFA) was measured using a NEFA kit (WAKO, Osaka, Japan). 
Serum creatinine was measured using the Architect C16000 Clinical Chemistry Analyzer (Abbott Laboratories, 
Abbott Park, Ill, USA).
Analysis of renal structural changes.  Formalin-fixed hemisected kidneys were embedded in paraffin 
and stained with Masson’s trichrome or Periodic Acid Schiff (PAS). They were examined using a light microscope 
(Leica photomicroscope linked to a DFC 480 digital camera) and five non-overlapping fields were captured for 
each kidney. Tubular interstitial injury was an aggregate measure of tubular dilatation, separation, atrophy and 
interstitial fibrosis as measured by a blinded independent nephrologist. Images were analyzed using an Olympus 
microscope (Olympus, Japan) and Image J software.
Protein extraction and western blotting.  In order to extract protein, 10 mg kidney tissue was washed 
with phosphate buffered saline (PBS, pH 7.4, containing 0.16 mg/ml heparin to remove any red blood cells and 
clots) then the tissue was extracted with a Qiagen TissueRuptur (Qiagen, Limburg, Netherlands) in 1.5 ml of 
cold 20 mM HEPES buffer (pH 7.2, containing 1 mM EGTA, 210 mM mannitol, 70 mM sucrose) and quanti-
fied (BioRad, CA, USA). A total of 20 μg of protein sample was loaded onto a NuPAGE SDS-PAGE gel (Life 
Technologies, CA, USA) and electroblotted to Hybond Nitrocellulose membranes (Amersham Pharmacia 
Biotech, Bucks, UK). The membranes were incubated overnight at 4 °C with the following primary antibodies: 
fibronectin (dilution 1:1000, Abcam, Cambridge, UK), collagen IV (1:1000, Abcam), and MnSOD (1:1000, Merck 
Millipore Ltd., Darmstadt, Germany), followed by horseradish peroxidase conjugated secondary antibody (Life 
Technologies, CA, USA). Proteins were visualized using Luminata Western HRP Substrate (Millipore, MA, USA) 
in a LAS 4000 image reader (Fujifilm, Tokyo, Japan). All membranes were re-probed with β-actin 1:1000 (Santa 
Cruz, CA, USA) and results were expressed as percentage of protein expression relative to β-actin. Analysis was 
performed using Image J software (Java based software program, National Institutes of Health).
Immunohistochemistry.  Formalin-fixed paraffin kidney sections were deparaffinised and incubated 
overnight with the polyclonal primary antibody against fibronectin (dilution 1:1,000, Abcam Ltd, Cambridge), 
collagen IV (dilution 1:1,000, Abcam), CD68 (1:100, ABD Serotec, USA), F4/80 (1:100, ABD Serotec), 8OHdg 
(1:200, Cell Signalling Ltd) followed by horseradish peroxidase anti-rabbit Envision system (Dako Cytochemistry, 
Tokyo, Japan) the following day. Staining was developed with 3.3diaminobenzidine tetrahydrochloride (Dako 
Cytochemistry, Tokyo, Japan) before counterstaining with Mayer’s haematoxylin stains. Antibody against rabbit 
IgG was used as a negative control. Images were analyzed as described above.
Relative quantitative real-time PCR (RT-PCR).  RNA was extracted using RNeasy mini kit (Qiagen, 
Valencia, CA, USA). cDNA was generated using Transcriptor First Strand cDNA Synthesis Kits (Roche 
Diagnostics, Mannheim, Germany). RT-PCR was performed using an ABI Prism 7900 HT Sequence Detection 
System (Applied Biosystems, Foster City, CA, USA). SYBR GreenER qPCR Supermix (Invitrogen) with PCR 
primers was used (Table 2). Results are presented as fold change compared to control after normalization to 
β-Actin.
Figure 6. Schematic representation of the mouse model of maternal obesity and offspring diabetes. 
Offspring from lean mothers (control): CC-ctrl, type 1 diabetic offspring from lean mothers: CC-T1D, offspring 
from obese mothers: HC-ctrl and offspring from obese mothers with type 1 diabetes: HC-T1D.
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Statistical methods. All results are expressed as mean ± SEM. Data were analyzed using analysis of vari-
ance (ANOVA), followed by post hoc Bonferroni tests using GraphPad Prism 6.0 (GraphPad Software, San Diego, 
CA, USA). A P value of <0.05 was considered statistically significant.
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